跳至主要内容
临床试验/CTRI/2017/02/007886
CTRI/2017/02/007886已完成4 期

A comparative study of efficacy and safety of Duloxetine 40mg vs Duloxetine 60mg in patients with taxane induced peripheral neuropathy.

Mysore Medical College and Research Institute0 个研究点目标入组 44 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Age > 18 years of age.
  • 2)All patients who received Paclitaxel 175mg/m2 and should have developed peripheral neuropathy due to paclitaxel.
  • 3)Had > grade 1 sensory CIPN based on NCI Common Toxicity Criteria for Adverse Events (CTCAE) V.4.0. grading scale.
  • 4)Patients with any cancer diagnosis or stage .
  • 5)No precedent peripheral neuropathy.

排除标准

  • Participants with a documented medical history of
  • 1)Preceding neuropathy due to Diabetes mellitus.
  • 2)Neuropathy from any other type of nerve compression ( eg. Carpal / tarsal tunnel syndrome, radiculopathy , spinal stenosis, brachial plexopathy).
  • 3)Severe depression.
  • 4)Suicidal ideation.
  • 5)Bipolar disorder.
  • 6)Alcohol abuse.
  • 7)Markedly abnormal renal or liver function test.

研究者

发起方
Mysore Medical College and Research Institute

相似试验